• Je něco špatně v tomto záznamu ?

Prevention of multidrug-resistant infections from contaminated duodenoscopes: Position Statement of the European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology Nurses and Associates (ESGENA)

U. Beilenhoff, H. Biering, R. Blum, J. Brljak, M. Cimbro, JM. Dumonceau, C. Hassan, M. Jung, C. Neumann, M. Pietsch, L. Pineau, T. Ponchon, S. Rejchrt, JF. Rey, V. Schmidt, J. Tillett, J. van Hooft,

. 2017 ; 49 (11) : 1098-1106. [pub] 20171016

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, směrnice pro lékařskou praxi, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc18024558

Patients should be informed about the benefits and risks of endoscopic retrograde cholangiopancreatography (ERCP)Only specially trained and competent personnel should carry out endoscope reprocessing.Manufacturers of duodenoscopes should provide detailed instructions on how to use and reprocess their equipment.In the case of modifications to their equipment, manufacturers should provide updated instructions for use.Detailed reprocessing protocols based on the manufacturer's instructions for use should clearly lay out the different reprocessing steps necessary for each endoscope model.Appropriate cleaning equipment should be used for duodenoscopes in compliance with the manufacturer's instructions for use. Only purpose-designed, endoscope type-specific, single-use cleaning brushes should be used, to ensure optimal cleaning. As soon as the endoscope is withdrawn from the patient, bedside cleaning should be performed, followed by leak testing, thorough manual cleaning steps, and automated reprocessing, in order to: · Remove debris from external and internal surfaces;. · Prevent any drying of body fluids, blood, or debris;. · Prevent any formation of biofilms.. In addition to the leak test, visual inspection of the distal end as well as regular maintenance of duodenoscopes should be performed according to the manufacturer's instructions for use, in order to detect any damage at an early stage.The entire reprocessing procedure in endoscope washer-disinfectors (EWDs) should be validated according to the European and International Standard, EN ISO 15883. Routine technical tests of EWDs should be performed according to the validation reports.Microbiological surveillance of a proportion of the department's endoscopes should be performed every 3 months, with the requirement that all endoscopes used in the unit are tested at least once a year.In the case of suspected endoscopy-related infection, the relevant device (e. g., endoscope, EWD) should be taken out of service until adequate corrective actions have been taken. Outbreaks should be managed by a multidisciplinary team, including endoscopy, hygiene, and microbiology experts, manufacturers, and regulatory bodies, according to national standards and/or laws. In the case of suspected multidrug-resistant organism (MDRO) outbreaks, close cooperation between the endoscopy unit and the clinical health provider is essential (including infection control departments and hospital hygienists).

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18024558
003      
CZ-PrNML
005      
20180713120931.0
007      
ta
008      
180709s2017 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1055/s-0043-120523 $2 doi
035    __
$a (PubMed)29036747
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Beilenhoff, Ulrike $u ESGENA Scientific Secretary, Ulm, Germany.
245    10
$a Prevention of multidrug-resistant infections from contaminated duodenoscopes: Position Statement of the European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology Nurses and Associates (ESGENA) / $c U. Beilenhoff, H. Biering, R. Blum, J. Brljak, M. Cimbro, JM. Dumonceau, C. Hassan, M. Jung, C. Neumann, M. Pietsch, L. Pineau, T. Ponchon, S. Rejchrt, JF. Rey, V. Schmidt, J. Tillett, J. van Hooft,
520    9_
$a Patients should be informed about the benefits and risks of endoscopic retrograde cholangiopancreatography (ERCP)Only specially trained and competent personnel should carry out endoscope reprocessing.Manufacturers of duodenoscopes should provide detailed instructions on how to use and reprocess their equipment.In the case of modifications to their equipment, manufacturers should provide updated instructions for use.Detailed reprocessing protocols based on the manufacturer's instructions for use should clearly lay out the different reprocessing steps necessary for each endoscope model.Appropriate cleaning equipment should be used for duodenoscopes in compliance with the manufacturer's instructions for use. Only purpose-designed, endoscope type-specific, single-use cleaning brushes should be used, to ensure optimal cleaning. As soon as the endoscope is withdrawn from the patient, bedside cleaning should be performed, followed by leak testing, thorough manual cleaning steps, and automated reprocessing, in order to: · Remove debris from external and internal surfaces;. · Prevent any drying of body fluids, blood, or debris;. · Prevent any formation of biofilms.. In addition to the leak test, visual inspection of the distal end as well as regular maintenance of duodenoscopes should be performed according to the manufacturer's instructions for use, in order to detect any damage at an early stage.The entire reprocessing procedure in endoscope washer-disinfectors (EWDs) should be validated according to the European and International Standard, EN ISO 15883. Routine technical tests of EWDs should be performed according to the validation reports.Microbiological surveillance of a proportion of the department's endoscopes should be performed every 3 months, with the requirement that all endoscopes used in the unit are tested at least once a year.In the case of suspected endoscopy-related infection, the relevant device (e. g., endoscope, EWD) should be taken out of service until adequate corrective actions have been taken. Outbreaks should be managed by a multidisciplinary team, including endoscopy, hygiene, and microbiology experts, manufacturers, and regulatory bodies, according to national standards and/or laws. In the case of suspected multidrug-resistant organism (MDRO) outbreaks, close cooperation between the endoscopy unit and the clinical health provider is essential (including infection control departments and hospital hygienists).
650    _2
$a infekce spojené se zdravotní péčí $x mikrobiologie $x prevence a kontrola $7 D003428
650    _2
$a dekontaminace $x metody $x normy $7 D003666
650    12
$a mnohočetná léková rezistence $7 D018432
650    _2
$a duodenoskopy $x mikrobiologie $x normy $7 D020698
650    _2
$a kontaminace zdravotnického vybavení $x prevence a kontrola $7 D004866
650    _2
$a lidé $7 D006801
650    _2
$a kontrola infekce $x metody $7 D017053
655    _2
$a časopisecké články $7 D016428
655    _2
$a směrnice pro lékařskou praxi $7 D017065
655    _2
$a přehledy $7 D016454
700    1_
$a Biering, Holger $u Grevenbroich, Germany.
700    1_
$a Blum, Reinhard $u Olympus Europa, Hamburg, Germany.
700    1_
$a Brljak, Jadranka $u University Hospital KBC-Zagreb-Rebro, Zagreb, Croatia.
700    1_
$a Cimbro, Monica $u Medical Devices Division, CBC Europe Srl, Nova Milanese (MB), Italy.
700    1_
$a Dumonceau, Jean-Marc $u Gedyt Endoscopy Center, Buenos Aires, Argentina.
700    1_
$a Hassan, Cesare $u Digestive Endoscopy Unit, Catholic University, Rome, Italy.
700    1_
$a Jung, Michael $u 2nd Department of Internal Medicine, Katholisches Klinikum, Mainz, Germany.
700    1_
$a Neumann, Christiane $u ESGENA Past President, Birmingham, UK.
700    1_
$a Pietsch, Michael $u Department of Hygiene and Infection Prevention, Medical Center, University Hospital, Mainz, Germany.
700    1_
$a Pineau, Lionel $u Biotech Germande, Marseille, France.
700    1_
$a Ponchon, Thierry $u Digestive Diseases Department, Hôpital Edouard Herriot, Lyon, France.
700    1_
$a Rejchrt, Stanislav $u 2nd Department of Internal Medicine, Charles University Teaching Hospital, Hradec Králové, Czech Republic.
700    1_
$a Rey, Jean-François $u Institut Arnault Tzanck, St. Laurent du Var, France.
700    1_
$a Schmidt, Verona $u Microbiology and Hygiene Department, Chemische Fabrik Dr. Weigert, Hamburg, Germany.
700    1_
$a Tillett, Jayne $u St. Woolos Hospital, Newport, UK.
700    1_
$a van Hooft, Jeanin $u Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands.
773    0_
$w MED00009605 $t Endoscopy $x 1438-8812 $g Roč. 49, č. 11 (2017), s. 1098-1106
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29036747 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180709 $b ABA008
991    __
$a 20180713121225 $b ABA008
999    __
$a ok $b bmc $g 1316689 $s 1021479
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 49 $c 11 $d 1098-1106 $e 20171016 $i 1438-8812 $m Endoscopy $n Endoscopy $x MED00009605
LZP    __
$a Pubmed-20180709

Najít záznam

Citační ukazatele

Možnosti archivace